Vijaya Diagnostic Centre Limited

NSE:VIJAYA India Diagnostics & Research
Market Cap
$1.12 Billion
₹96.92 Billion INR
Market Cap Rank
#9979 Global
#413 in India
Share Price
₹941.90
Change (1 day)
-1.42%
52-Week Range
₹891.20 - ₹1144.20
All Time High
₹1241.80
About

Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T ser… Read more

Vijaya Diagnostic Centre Limited - Asset Resilience Ratio

Latest as of September 2025: 16.44%

Vijaya Diagnostic Centre Limited (VIJAYA) has an Asset Resilience Ratio of 16.44% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
₹2.29 Billion
Cash + Short-term Investments
Total Assets
₹13.91 Billion
All company assets
Resilience Assessment
Good
Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Vijaya Diagnostic Centre Limited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Vijaya Diagnostic Centre Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₹0.00 0%
Short-term Investments ₹2.29 Billion 16.44%
Total Liquid Assets ₹2.29 Billion 16.44%

Asset Resilience Insights

  • Good Liquidity Position: Vijaya Diagnostic Centre Limited maintains a healthy 16.44% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Vijaya Diagnostic Centre Limited Industry Peers by Asset Resilience Ratio

Compare Vijaya Diagnostic Centre Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
ADCNF
OTCGREY:ADCNF
Diagnostics & Research 1.12%
Berry Genomics Co Ltd
SHE:000710
Diagnostics & Research 0.45%
NSN Co. Ltd
KQ:031860
Diagnostics & Research 1.72%
JOONGANG DNM Co.Ltd
KQ:051980
Diagnostics & Research 27.26%
GeneMatrix Inc
KQ:109820
Diagnostics & Research 41.52%
Genoray Co. Ltd
KQ:122310
Diagnostics & Research 0.03%
Green Cross Lab Cell Corporation
KQ:144510
Diagnostics & Research 0.18%
Optipharm.CO.LTD
KQ:153710
Diagnostics & Research 20.73%

Annual Asset Resilience Ratio for Vijaya Diagnostic Centre Limited (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Vijaya Diagnostic Centre Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 14.49% ₹1.85 Billion ₹12.74 Billion +3.39pp
2024-03-31 11.10% ₹1.09 Billion ₹9.83 Billion -15.99pp
2023-03-31 27.10% ₹2.31 Billion ₹8.53 Billion -2.91pp
2022-03-31 30.01% ₹2.14 Billion ₹7.13 Billion -9.35pp
2021-03-31 39.36% ₹2.13 Billion ₹5.41 Billion +15.49pp
2020-03-31 23.86% ₹1.15 Billion ₹4.82 Billion -3.16pp
2019-03-31 27.03% ₹1.10 Billion ₹4.06 Billion --
pp = percentage points